US Sees Record Surge in Whooping Cough Cases

The United States is experiencing its highest number of whooping cough cases in nearly a decade, with over 32,000 cases reported this year, according to recent data from the Centers for Disease Control and Prevention (CDC). This represents a sixfold increase compared to the same time last year and marks the highest tally since 2014.

Whooping cough, medically known as pertussis, is a highly contagious bacterial respiratory illness. It often begins with symptoms resembling the common cold, such as a runny nose, sneezing, mild fever, and a tickling cough. However, after one to two weeks, the illness can progress into severe coughing fits that may result in vomiting, broken ribs, or extreme exhaustion. A distinctive “whooping” sound frequently accompanies the cough as individuals struggle to breathe.

The infection is particularly concerning due to its prolonged contagious period; individuals can spread the bacteria for weeks after symptoms develop. In mild cases, some may unknowingly pass on the infection, further fueling its spread.

Rising Cases Post-Pandemic

During the COVID-19 pandemic, cases of whooping cough, like many respiratory illnesses, dropped significantly due to widespread social distancing and mask-wearing. However, the CDC reports that cases have sharply increased this year, doubling since September alone. Nearly a quarter of all cases have been reported in the Midwest, with Pennsylvania recording the highest number of infections nationwide.

Whooping cough outbreaks follow a cyclical pattern, with peaks occurring every few years. Experts suggest the current surge reflects a return to pre-pandemic trends.

Vulnerable Populations at Risk

While whooping cough can affect individuals of all ages, infants and young children are particularly vulnerable. Babies under one year of age, whose immune systems are still developing, face the greatest risk of severe complications, including pneumonia and death. Unvaccinated children are especially susceptible, making vaccination a critical line of defense.

The CDC recommends the DTaP vaccine for children and the TDaP vaccine for adolescents and adults. However, vaccination rates have fallen, with only 92% of kindergartners receiving the DTaP vaccine in the 2023-2024 school year. This is below the federal target of 95%, leaving many children unprotected. Additionally, immunity from the vaccine can wane over time, necessitating booster shots to maintain protection.

Managing the Illness

Antibiotics can effectively treat whooping cough, but only if administered in the early stages of the illness, before the onset of severe coughing fits. Once the cough takes hold, treatment is limited to comfort care, which includes rest, hydration, and managing symptoms as the infection resolves.

Concerns Amid Broader Respiratory Illness Activity

The surge in whooping cough cases comes as the United States faces increased activity from other respiratory illnesses, including COVID-19 and influenza, as winter approaches. Public health experts emphasize the importance of vaccinations, early diagnosis, and proactive measures to prevent further spread of these illnesses.

This alarming rise in whooping cough underscores the need for vigilance, community health awareness, and robust vaccination programs to protect vulnerable populations and curb the spread of this preventable disease.